|
|
|
|
-
The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
- Ren, Yijiu; Dai, Chenyang; Shen, Jianfei; Liu, Yang; Xie, Dong; Zheng, Hui; He, Jiaxi*; Liang, Wenhua; Jiang, Gening; Fei, Ke; Yang, Ping; He, Jianxing; Chen, Chang*
- Oncotarget, 2016, 7(18): 26856-26865.
-
|
|
|
|